Get the Stockscreener App
3.95
1.54%
0.06
Aurora Cannabis Inc. stock is traded at $3.95, with a volume of 677.38K.
It is up +1.54% in the last 24 hours and up +40.57% over the past month.
Aurora Cannabis Inc. produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company's products consist of dried cannabis and cannabis oil; CanniMed vegan capsules; and hemp products, as well as sells vaporizers, consumable vaporizer accessories, and herb mills for using herbal cannabis products. It also operates CanvasRX, a network of cannabis counseling and outreach centers; and provides cannabis analytical product testing services. The company has operations in 19 countries across five continents. Aurora Cannabis Inc. has collaboration agreements with PharmaChoice, Pharmasave, and Shoppers Drug Mart for the distribution, sale, and marketing of medical cannabis products through their respective networks of pharmacies. The company has a strategic agreements with Hempco Food and Fiber Inc.; CTT Pharmaceuticals Inc.; Choom Holdings Inc.; Capcium Inc.; The Green Organic Dutchman Holdings Ltd.; Société des Alcools du Québec; Alcanna; Radient Technologies; Micron Waste; Wagner Dimas; Evio; and Cann Group Limited. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
See More
Previous Close:
$3.89
Open:
$3.89
24h Volume:
677.38K
Relative Volume:
0.52
Market Cap:
$250.07M
Revenue:
$267.06M
Net Income/Loss:
$-69.17M
P/E Ratio:
-3.4937
EPS:
-1.1306
Net Cash Flow:
$-22.38M
1W Performance:
-1.50%
1M Performance:
+40.57%
6M Performance:
+8.22%
1Y Performance:
-18.22%
1-Day Range:
$3.8605
$3.97
1-Week Range:
$3.82
$4.15
52-Week Range:
$2.56
$6.665
Aurora Cannabis Inc. Stock (ACB) Company Profile
Name
Aurora Cannabis Inc.
Sector
Phone
-
Address
10355 Jasper Avenue, Suite 500, Edmonton, AB
Compare ACB vs TAK, TEVA, HLN, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACB
Aurora Cannabis Inc.
|
3.95 | 241.21M | 267.06M | -69.17M | -22.38M | -1.1306 |
TAK
Takeda Pharmaceutical Co Adr
|
18.45 | 57.90B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.36 | 42.89B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.60 | 43.41B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
75.81 | 31.00B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
487.61 | 22.35B | 3.17B | 1.29B | 1.01B | 27.09 |
Aurora Cannabis Inc. Stock (ACB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-27-26 | Initiated | Canaccord Genuity | Buy |
| Dec-11-24 | Initiated | TD Cowen | Buy |
| Feb-09-24 | Upgrade | Canaccord Genuity | Hold → Buy |
| Sep-21-22 | Upgrade | Canaccord Genuity | Sell → Hold |
| Jun-24-22 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Jun-06-22 | Upgrade | Stifel | Sell → Hold |
| Sep-28-21 | Upgrade | MKM Partners | Sell → Neutral |
| Sep-03-21 | Upgrade | Jefferies | Underperform → Hold |
| May-14-21 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
| May-14-21 | Downgrade | Canaccord Genuity | Hold → Sell |
| May-11-21 | Downgrade | CIBC | Neutral → Sector Underperform |
| Apr-28-21 | Resumed | BofA Securities | Neutral |
| Feb-12-21 | Downgrade | Desjardins | Hold → Sell |
| Feb-12-21 | Downgrade | MKM Partners | Neutral → Sell |
| Feb-12-21 | Downgrade | Needham | Hold → Underperform |
| Dec-18-20 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| Nov-16-20 | Downgrade | Jefferies | Hold → Underperform |
| Nov-11-20 | Downgrade | Stifel | Hold → Sell |
| Oct-27-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Sep-21-20 | Upgrade | Jefferies | Underperform → Hold |
| Sep-08-20 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Jun-24-20 | Upgrade | Stifel | Sell → Hold |
| May-22-20 | Downgrade | Jefferies | Hold → Underperform |
| May-15-20 | Upgrade | Piper Sandler | Underweight → Neutral |
| Feb-27-20 | Downgrade | Bryan Garnier | Neutral → Sell |
| Feb-25-20 | Initiated | Needham | Hold |
| Feb-24-20 | Downgrade | Cowen | Outperform → Market Perform |
| Feb-14-20 | Upgrade | MKM Partners | Sell → Neutral |
| Feb-07-20 | Downgrade | Canaccord Genuity | Speculative Buy → Hold |
| Jan-10-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-10-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-23-19 | Downgrade | Jefferies | Buy → Hold |
| Nov-15-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Nov-05-19 | Initiated | Cantor Fitzgerald | Neutral |
| Sep-24-19 | Initiated | CIBC | Neutral |
View All
Aurora Cannabis Inc. Stock (ACB) Latest News
Aurora Cannabis Inc. stock rises Friday, outperforms market - MarketWatch
Aurora Cannabis (NASDAQ:ACB) Global Medical Strategy Under Focus - Kalkine Media
Cannabis Operator CGC Rises 15% in a Month: Time to Buy, Hold or Sell? - TradingView
Curaleaf's Hostile Takeover Bid for Aurora Is Just the Tip of the Iceberg for Cannabis Consolidation. These 2 Stocks Could Be the Biggest Winners. - Yahoo Finance
Curaleaf's Hostile Takeover Bid for Aurora Is Just the Tip of the Iceberg for Cannabis Consolidation. These 2 Stocks Could Be the Biggest Winners. - The Motley Fool
StockTalk | Cannabis Report: Hostile takeover? | 2026-08-21 | Investing News - Stockhouse
Aurora Cannabis Inc. stock falls Thursday, underperforms market - MarketWatch
Aurora Cannabis Company Profile & Introduction - Moomoo
Aurora Cannabis Acquires Internode Pharma, HAP Pharma, Expanding Distribution Access to UK - Cannabis Business Times
Aurora Cannabis expands in UK market through acquisitions - The Pharma Letter
Small caps to watch: Roots announces go-private deal, along with updates from Questerre Energy, Tilray and Aurora - The Globe and Mail
Aurora expands UK distribution with new company acquisitions - MMJDaily
Is Curaleaf Stock a Buy With Its Attempted Hostile Takeover of Aurora Cannabis Under Way? - Yahoo Finance
Can Aurora Cannabis (TSX:ACB) Defy Changing Market Sentiment? - Kalkine Media
Aurora Cannabis Inc. stock rises Wednesday, outperforms market - MarketWatch
Aurora Cannabis Buys Internode Pharma & HAP Pharma - TradingView
Aurora Cannabis Buys U.K. Importer and Pharmacy to Deepen Medical Cannabis Reach - TipRanks
Aurora Cannabis Furthers Global Medical Cannabis Growth with Accretive Acquisition of Internode Pharma Limited and HAP Pharma Limited, Expanding Distribution Access to the UK Medical Cannabis Market - Investing News Network
Aurora Cannabis Bolsters its UK Supply Chain with New Acquisitions - StratCann
ATB Cormark Capital Markets Downgrades Aurora Cannabis (TSE:ACB) to Tender - MarketBeat
Aurora Cannabis acquires UK pharma firms for £2.1 million By Investing.com - Investing.com Australia
Aurora Cannabis Acquires UK's Internode Pharma, HAP Pharma for $2.86 Million - marketscreener.com
Aurora Cannabis Acquiring UK Company For 2 Million Pounds Cash - marketscreener.com
Tilray Jumps 6%, Canopy Growth Climbs 3%, Aurora Cannabis Gains 4%: Here’s Why TLRY Is Still Down 47% YTD - Yahoo Finance
Curaleaf-Aurora Deal Unlocks Post-Closing Upside Despite Lower Base Offer -- Market Talk - Moomoo
Aurora Cannabis acquires UK pharma firms for £2.1 million - Investing.com
Aurora Cannabis Urges Shareholders to Take No Action on Curaleaf’s Unsolicited Takeover Bid - Cannabis Business Times
Aurora Cannabis Inc. - Baystreet.ca
Stocks in play: Aurora Cannabis Inc. - Barchart.com
Aurora Cannabis urges shareholders to reject Curaleaf bid By Investing.com - Investing.com South Africa
Aurora Cannabis Tells Shareholders to Ignore Curaleaf's Unsolicited Offer - marketscreener.com
Aurora Accuses Curaleaf of Trying to Buy It ‘at the Lowest Price Possible’ - the deep dive
Curaleaf launches its formal bid for Aurora, and Aurora tells shareholders to take no action - MMJDaily
Aurora Cannabis shareholders urged to wait on Curaleaf bid - Seeking Alpha
Aurora Cannabis Ticks Up as International Medical Momentum Steadies the Story - kalkine.ca
ACB Looks 4.9% Undervalued on GF Value™ Despite Unsolicited Take - GuruFocus
Aurora Cannabis Tells Investors to Sit Tight as Curaleaf Launches Hostile Bid - TipRanks
Aurora Cannabis urges shareholders to reject Curaleaf bid - Investing.com
Aurora Cannabis tells shareholders to wait on Curaleaf's $4 takeover bid - StreetInsider
AURORA CANNABIS INC. URGES SHAREHOLDERS TO TAKE NO ACTION AT THIS TIME IN RESPECT TO THE UNSOLICITED TAKE-OVER BID BY CURALEAF HOLDINGS, INC. - PR Newswire
Aurora (ACB) Results Breakdown: Reported EPS Tops Expectations in the Current Update; Share Move - Vinanet
Curaleaf launches takeover bid for Aurora Cannabis at $4 per share - Investing.com Nigeria
Curaleaf Advances Aurora Acquisition Strategy with Direct Shareholder Offer - StratCann
Aurora Cannabis Inc. stock rises Tuesday, outperforms market - MarketWatch
Curaleaf launches US$260 million bid for Canadian producer Aurora Cannabis - BNN Bloomberg
Curaleaf Launches Takeover Bid to Acquire Aurora Cannabis, Invites Aurora Shareholders to Tender Bid - Cannabis Business Times
Curaleaf launches $260-million takeover bid for Aurora Cannabis - The Globe and Mail
Curaleaf Launches Hostile Bid for Aurora Cannabis - TipRanks
Curaleaf launches US$260 million takeover bid for Canadian producer Aurora Cannabis - BNN Bloomberg
Curaleaf launches $260 million takeover bid for Aurora Cannabis - TradingView
Curaleaf Launches Formal Take-Over Bid for Aurora Cannabis - Minichart
Aurora Cannabis Inc. Stock (ACB) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.66%
0.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):